
Owns logistics warehouses worldwide and leases them to shippers and retailers.
Prologis at a glance: how it scores on value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.
Strong business, priced for a lot of it - 18 of 36 checks passed.
What you pay today for what the business produces, measured against PLD's own history and its peers, never a universal rule.
Expensive against its own history and its sector - you're paying up for what you get.
→At 34.6x earnings, the market is paying +23% more than PLD's own 10-year median of 28.1x. Expectations are elevated, so more has to go right to justify the price.
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 34.6x earnings, the market is paying +23% more than PLD's own 10-year median of 28.1x. Expectations are elevated, so more has to go right to justify the price.
Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.
| – | Cheaper than its own history (earnings) | no multiple history |
| ✕ | Earnings yield beats a long bond (4%) | 2.9% vs 4.0% |
| – | Better cash yield than its own history | under 3 years of cash-flow history |
| ✕ | FFO yield above 5% | 4.6% vs 5.0% |
| ✕ | Cheap on FFO | 21.93 vs 16.00 (peer median) |
| ✕ | Price isn't outrunning growth | no positive three-year earnings growth behind the price |
What the company has actually reported - is it selling more, and is more of it becoming profit?
Growth is weak or inconsistent - the trend, not the story, is the problem.
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $8.8B in 2025, compounding +14% a year since 2022 though the pace has cooled. The last twelve months (+7%) ran below that pace, so growth is slowing.
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $3.3B in 2025, compounding -0% a year over three years. Trailing twelve-month profit stands at $3.8B.
+7%revenue growth, FY 2025
→In 2025 revenue grew +7% while earnings moved -11% - when the earnings line runs above revenue, each new dollar of sales is arriving more profitably.
Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).
| ✕ | Outgrew its sector last year | 6.7% vs 7.7% (sector 70th pct, n=179) |
| ✕ | Sustained growth beats its sector (3 years) | 13.7% vs 16.1% (sector 70th pct, n=170) |
| ✕ | Profits grew last year | -0.1% vs 0.0% |
| ✕ | Profit growth beats its peers | -5.7% vs 16.5% (sector 70th pct, n=118) |
| ✕ | Growth is speeding up, not slowing | 1y 6.7% vs 3y 13.7% |
| ✕ | Grew per share, not just in total (FFO per share) | -2.5% vs 0.0% |
Whether the growth makes real money - margins, returns on capital, and whether profits turn into cash.
Rare profitability: margins and returns on capital are well above its peers.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-03-31), not a full fiscal year
→Operating margin compressed 8 points to 50% since 2022. After everything, 38 cents of each sales dollar reaches net profit. PLD doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-03-31), not a full fiscal year
→Operating cash flow runs at 135% of reported profit, so the earnings are more than backed by cash - depreciation and other non-cash charges are understating what the business actually collects.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-03-31), not a full fiscal year
→ROE of 6% on shareholders' capital (ROCE isn't meaningful for this business model).
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
Net income plus property depreciation, less gains on property sales - the measure REITs are actually valued on, because a building does not lose value on the schedule the accounts assume.
→PLD generated $6.0B of funds from operations in 2025, growing +5% a year over three years. FFO adds back depreciation because a REIT's buildings do not really wear out the way the accounts assume. Per share that is $6.22, +583% since 2011 - the number REIT investors actually compare.
→PLD earns 6.3% on the capital it employs, below the 10% most investors treat as the cost of capital. It was 6.3% in 2022, so the trend is flat, though the path has been bumpy.
Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.
| ✓ | Turns more rent into FFO than peers | 65.3% vs 47.1% (sector 70th pct, n=172) |
| ✓ | Keeps more of its rent as profit than peers | 42.5% vs 18.5% (sector 70th pct, n=187) |
| ✓ | Actually profitable | TTM net income $3.8B |
| ✓ | Earns well on shareholders' money | 7.1% vs 6.2% (sector 70th pct, n=197) |
| ✓ | FFO is a real return on its property | 6.0% vs 4.5% |
| ✓ | Profits are cash, not accounting | 1.35 vs 0.80 |
The balance sheet stress test: could PLD survive a bad year?
A fortress balance sheet - PLD can survive a very bad year.
→Debt of $34.7B sits against $861M of cash, or 0.6x shareholders' equity. Earnings cover interest 4.6 times - adequate, with less room than it looks in a downturn.
→The company's own capital grew from $53.2B in 2023 to $53.5B (+1%). The business is building book value rather than consuming it.
Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.
| ✓ | Leverage is under control | 40.9% vs 60.0% |
| ✓ | Less levered than its peers | 0.41 vs 0.48 (sector 30th pct, n=221) |
| ✕ | Debt trending the right way | debt/equity 0.65 now vs 0.01 five years ago |
| ✓ | FFO covers the interest | 5.70 vs 2.00 |
| ✓ | Converts sales to cash better than its sector | 57.4% vs 50.1% (sector 70th pct, n=186) |
| ✓ | FFO covers interest and the distribution | FFO covers 1.22x interest plus distributions |
How much cash actually flows back to owners - dividends, buybacks, whether the share count truly falls, and whether what is handed back is affordable.
Cash does come back to owners, but the share count is still climbing - part of it is recycling.
→0.3% more shares last year - your stake was diluted by that much.
→Up from $2.28 to $3.93 per share over 5 years - the cheque keeps growing.
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At today's price the yield is 2.9%.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-03-31), not a full fiscal year
→Stretched: 113% of profits and 75% of free cash flow go out as dividends - most of what the business generates, so a cut gets likelier in a bad year.
Both lines start at 100 in 2011, so the gap between them is what each share gained or lost. Share counts are split-adjusted.
→PLD issued +157% more shares from 2011 to 2025, but FFO per share still rose +583%. The dilution bought more growth than it cost existing holders.
A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.
| ✕ | Share count isn't climbing | shares up 17.9% over 3 years |
| ✕ | Buybacks outpace the stock issued to staff | no buybacks against $193M of stock compensation |
| ✓ | What it hands back fits inside its FFO | 65.5% vs 100.0% |
| ✓ | Meaningful yield to owners (dividends and buybacks) | $3.8B returned, 3.0% of market value |
| ✓ | Reliable payer, never cut | paid 10/10 years, worst year-on-year change 5.4% |
| ✓ | Dividend growing ahead of inflation | 50.9% vs 9.0% |
What the market is doing about all of the above. This is price behaviour, not a fact about the business - read it as the market's current opinion, scored on six checks like every other chapter. The market is the S&P 500, measured by the SPY ETF with dividends included, over 3 months (63 trading sessions) and 12 months (252).
Mixed signals from the market - some trends up, some rolling over.
Chart by TradingView
→PLD is in a downtrend. The price is below the band where recent trading settled and that band is still falling, so nothing in the picture has turned yet. Both the last two weeks and the month-ago comparison point down as well, so nothing here disagrees with the downtrend. The band drawn for the coming weeks turns downward partway through, so that support is set to thin out from there. The band is unusually narrow at the moment, which makes it easy to cross in either direction.
The trend read comes from the daily Ichimoku picture, a standard trend indicator, translated out of its jargon. It builds a band from the midpoints of the last 9, 26 and 52 sessions' highs and lows - in effect, the range where recent trading has settled - and draws that band 26 sessions into the future. Price above the band is an uptrend, below it a downtrend, inside it no trend. Because the band is drawn forward, the support for the next few weeks is already fixed and a change of its direction can be seen coming. We also compare the last two weeks against the last month, and today's price against where it stood a month ago. None of this says anything about the business; it describes the price only, and it is not advice. Where a check says 'the S&P 500', the comparison is with the SPY ETF including dividends, on the same adjusted basis as the stock's own price: short means 3 months, 63 trading sessions; long means 12 months, 252.
| ✕ | Trading above its cloud | 0.00 vs 0.50 |
| ✓ | Long-term trend structure is healthy | 142.07 vs 136.11 |
| ✕ | Rising over 3 months | -4.3% vs 0.0% |
| ✕ | Beating the S&P 500 over 3 months | -4.3% vs 4.7% |
| ✓ | Beating the S&P 500 over 12 months | 25.9% vs 20.0% |
| ✓ | Not in a deep hole | -8.5% from its 52-week high |
What the people running the company do with their own shares - reported to the SEC within two days, classified so pay-plumbing doesn't masquerade as conviction.
→No open-market buying, and $8M of selling across 2 months. Selling alone is a weak signal - much of it is pre-scheduled - but the absence of buying tells you no insider saw the price as a bargain.
| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | Hamid Moghadam | Director | SELL | 50,000 | $7M |
| 2026-06-15 | Timothy D Arndt | Chief Financial Officer | SELL | 3,597 | $539,550 |
| 2026-04-28 | Irving F Iii Lyons | Director | conversion | 43,825 | $6M |
| 2026-04-28 | Olivier Piani | Director | tax | 595 | $84,210 |
Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.